HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

U Haberkorn Selected Research

U Haberkorn Research Topics

Disease

17Neoplasms (Cancer)
06/2015 - 10/2000
9Neoplasm Metastasis (Metastasis)
06/2015 - 10/2000
6Experimental Liver Neoplasms
11/2001 - 01/2001
5Prostatic Neoplasms (Prostate Cancer)
11/2015 - 06/2012
4Neuroendocrine Tumors (Neuroendocrine Tumor)
06/2015 - 10/2012
2Carcinoma (Carcinomatosis)
04/2013 - 05/2001
2Melanoma (Melanoma, Malignant)
01/2009 - 10/2000
2Hepatocellular Carcinoma (Hepatoma)
12/2001 - 11/2001
2Breast Neoplasms (Breast Cancer)
05/2001 - 01/2001
1Hypercalcemia (Milk Alkali Syndrome)
03/2013
1Hypercalciuria
03/2013
1Primary Hyperparathyroidism
03/2013
1Cicatrix (Scar)
04/2012
1Lymphoma (Lymphomas)
04/2012
1Anoxia (Hypoxia)
01/2007
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2006
1Osteomalacia
02/2005
1Merkel Cell Carcinoma
06/2003
1Lung Neoplasms (Lung Cancer)
09/2001
1Colorectal Neoplasms (Colorectal Cancer)
09/2001
1Thyroid Neoplasms (Thyroid Cancer)
07/2001
1Neurilemmoma (Schwannoma)
07/2001
1Meningioma (Meningiomas)
07/2001
1Neurofibroma
07/2001
1Glioblastoma (Glioblastoma Multiforme)
06/2001
1Sarcoma (Soft Tissue Sarcoma)
05/2001
1Adenocarcinoma
11/2000
1Experimental Melanoma
10/2000
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2000

Drug/Important Bio-Agent (IBA)

6(DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)IBA
06/2015 - 07/2001
6Glucose (Dextrose)FDA LinkGeneric
10/2011 - 04/2001
5Somatostatin Receptors (Somatostatin Receptor)IBA
06/2015 - 11/2000
4GalliumIBA
06/2013 - 05/2001
4Thymidine KinaseIBA
12/2001 - 07/2001
3N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
11/2015 - 04/2013
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
03/2015 - 06/2003
2Peptide Receptors (Peptide Receptor)IBA
06/2015 - 06/2013
2BenzamidesIBA
01/2009 - 10/2000
2AntibodiesIBA
04/2008 - 05/2001
2Octreotide (Sandostatin)FDA LinkGeneric
06/2003 - 07/2001
2Deoxyglucose (2 Deoxy D glucose)IBA
11/2001 - 01/2001
2hygromycin AIBA
02/2001 - 01/2001
1Urea (Carbamide)FDA LinkGeneric
11/2015
13-Tyr-octreotideIBA
06/2015
1Carbon MonoxideIBA
04/2013
1LigandsIBA
04/2013
1human glutamate carboxypeptidase IIIBA
04/2013
1Parathyroid Hormone (Parathormone)IBA
03/2013
1gadolinium ethoxybenzyl DTPAIBA
10/2012
1fluoroethylcholineIBA
06/2012
1ThymidineIBA
04/2012
1Biological Markers (Surrogate Marker)IBA
10/2011
1Serine (L-Serine)FDA Link
10/2011
1RadiopharmaceuticalsIBA
10/2011
1Proteins (Proteins, Gene)IBA
04/2008
1IonsIBA
03/2008
1Chelating AgentsIBA
03/2008
1NitroimidazolesIBA
01/2007
1cetuximab (Erbitux)FDA Link
01/2006
1Oncogenic osteomalaciaIBA
02/2005
1pentetreotide (OctreoScan)FDA Link
06/2003
1IndiumIBA
06/2003
1Ganciclovir (Cytovene)FDA LinkGeneric
12/2001
1MED 27IBA
12/2001
1Cytochalasin BIBA
11/2001
1enhanced green fluorescent proteinIBA
07/2001
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
07/2001
1fialuridineIBA
06/2001
1Acyclovir (Aciclovir)FDA LinkGeneric
06/2001
1anaplastic Thyroid cancerIBA
05/2001
1A-factor (Streptomyces)IBA
05/2001
1MucinsIBA
05/2001
1AntigensIBA
05/2001
1papillary Thyroid cancerIBA
05/2001
1NeomycinFDA LinkGeneric
05/2001
1gemcitabineFDA Link
04/2001
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2001
1Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA
11/2000
1sigma Receptors (sigma Receptor)IBA
10/2000
1benzamideIBA
10/2000
1ropinirole (Requip)FDA LinkGeneric
04/2000
1pramipexol (pramipexole)FDA LinkGeneric
04/2000
1Dopamine Agonists (Dopamine Agonist)IBA
04/2000
1Acetylcysteine (Siran)FDA LinkGeneric
04/2000
1MelatoninIBA
04/2000
1flupirtineIBA
04/2000
1idebenoneIBA
04/2000

Therapy/Procedure

3Aftercare (After-Treatment)
12/2001 - 04/2001
1Intra-Arterial Infusions
11/2014
1Drug Therapy (Chemotherapy)
04/2012
1Radioimmunotherapy
04/2008
1Organ Transplantation
10/2001
1Intravenous Injections
07/2001
1Injections
05/2001
1Heterologous Transplantation (Xenotransplantation)
05/2001